Zhao CL - Search Results

1

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.

Benza RL, Kanwar MK, Raina A, Scott JV, Zhao CL, Selej M, Elliott CG, Farber HW. Benza RL, et al. Among authors: zhao cl. Chest. 2021 Jan;159(1):337-346. doi: 10.1016/j.chest.2020.08.2069. Epub 2020 Sep 1. Chest. 2021. PMID: 32882243 Free PMC article.

2

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis.

Chakinala MM, Coyne DW, Benza RL, Frost AE, McGoon MD, Hartline BK, Frantz RP, Selej M, Zhao C, Mink DR, Farber HW. Chakinala MM, et al. J Heart Lung Transplant. 2018 Jun;37(6):696-705. doi: 10.1016/j.healun.2017.10.028. Epub 2017 Nov 6. J Heart Lung Transplant. 2018. PMID: 29174533

3

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.

Frantz RP, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Zhao C, Mink DR, Selej M, Benza RL. Frantz RP, et al. Chest. 2018 Jul;154(1):126-135. doi: 10.1016/j.chest.2018.01.009. Epub 2018 Jan 31. Chest. 2018. PMID: 29355551 Free PMC article.

4

Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL.

Farber HW, Badesch DB, Benza RL, Elliott CG, Frantz RP, McGoon MD, Selej M, Zhao C, Frost AE. Farber HW, et al. J Heart Lung Transplant. 2018 Aug;37(8):948-955. doi: 10.1016/j.healun.2018.03.010. Epub 2018 Mar 17. J Heart Lung Transplant. 2018. PMID: 29653800

5

Response.

Frantz RP, Zhao C, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Mink DR, Selej M, Benza RL. Frantz RP, et al. Chest. 2018 Nov;154(5):1262-1264. doi: 10.1016/j.chest.2018.07.033. Chest. 2018. PMID: 30409362 No abstract available.

6

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry.

Medrek S, Sahay S, Zhao C, Selej M, Frost A. Medrek S, et al. J Heart Lung Transplant. 2020 Apr;39(4):321-330. doi: 10.1016/j.healun.2019.11.024. Epub 2020 Jan 24. J Heart Lung Transplant. 2020. PMID: 32067864

7

Risk stratification in pulmonary arterial hypertension using Bayesian analysis.

Kanwar MK, Gomberg-Maitland M, Hoeper M, Pausch C, Pittrow D, Strange G, Anderson JJ, Zhao C, Scott JV, Druzdzel MJ, Kraisangka J, Lohmueller L, Antaki J, Benza RL. Kanwar MK, et al. Eur Respir J. 2020 Aug 27;56(2):2000008. doi: 10.1183/13993003.00008-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32366491 Free PMC article.

8

Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE.

Kim NH, Hemnes AR, Chakinala MM, Highland KB, Chin KM, McLaughlin V, Zhao C, Narayan V, Farber HW. Kim NH, et al. J Heart Lung Transplant. 2021 Apr;40(4):279-288. doi: 10.1016/j.healun.2021.01.006. Epub 2021 Jan 15. J Heart Lung Transplant. 2021. PMID: 33526303 Free article.

9

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.

Frost AE, Zhao C, Farber HW, Benza R, Yen J, Selej M, Elliott CG. Frost AE, et al. J Heart Lung Transplant. 2023 Mar;42(3):377-389. doi: 10.1016/j.healun.2022.10.007. Epub 2022 Oct 17. J Heart Lung Transplant. 2023. PMID: 36404264

10

Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.

El-Kersh K, Zhao C, Elliott G, Farber HW, Gomberg-Maitland M, Selej M, Garcia-Ferrer J, Benza R. El-Kersh K, et al. Chest. 2023 May;163(5):1232-1244. doi: 10.1016/j.chest.2022.12.045. Epub 2023 Jan 9. Chest. 2023. PMID: 36634897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page